{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:53:22Z","timestamp":1787921602315,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313664"],"award-info":[{"award-number":["2017A030313664"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Project of Yuexiu District of Guangzhou","award":["2017-W S-008"],"award-info":[{"award-number":["2017-W S-008"]}]},{"name":"Medical Science and Technology Research Funding of Guangdong Province","award":["A2019518"],"award-info":[{"award-number":["A2019518"]}]},{"name":"Science and Technology Planning Project of Guangzhou","award":["202002030253"],"award-info":[{"award-number":["202002030253"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00432-020-03301-y","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T07:24:27Z","timestamp":1593674667000},"page":"3063-3074","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome"],"prefix":"10.1007","volume":"146","author":[{"given":"Lanlan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6504-7577","authenticated-orcid":false,"given":"Xueyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"12","key":"3301_CR1","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","volume":"6","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Merrill SA, Alsawah F, Bockenstedt P, Campagnaro E, Devata S, Gitlin SD, Kaminski M, Cusick A, Phillips T, Sood S, Talpaz M, Quiery A, Boonstra PS, Wilcox RA (2019) Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol 6(12):e630\u2013e637. https:\/\/doi.org\/10.1016\/S2352-3026(19)30156-5","journal-title":"Lancet Haematol"},{"key":"3301_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","volume":"13","author":"H Al-Samkari","year":"2018","unstructured":"Al-Samkari H, Berliner N (2018) Hemophagocytic Lymphohistiocytosis. Ann Rev Pathol 13:27\u201349. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043625","journal-title":"Ann Rev Pathol"},{"issue":"19","key":"3301_CR3","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/bloodadvances.2017007526","volume":"1","author":"L Broglie","year":"2017","unstructured":"Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J (2017) Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. Blood Adv 1(19):1533\u20131536. https:\/\/doi.org\/10.1182\/bloodadvances.2017007526","journal-title":"Blood Adv"},{"issue":"1","key":"3301_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3892\/ol.2018.8783","volume":"16","author":"Y Chang","year":"2018","unstructured":"Chang Y, Cui M, Fu X, Han L, Zhang L, Li L, Li X, Sun Z, Wu J, Zhang X, Li Z, Nan F, Yan J, Sheng G, Zhang M (2018) Lymphoma associated hemophagocytic syndrome: a single-center retrospective study. Oncol Lett 16(1):1275\u20131284. https:\/\/doi.org\/10.3892\/ol.2018.8783","journal-title":"Oncol Lett"},{"issue":"27","key":"3301_CR5","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance AL, Lymphoma G, Eastern Cooperative Oncology G, European Mantle Cell Lymphoma C, Italian Lymphoma F, European Organisation for R, Treatment of Cancer\/Dutch Hemato-Oncology G, Grupo Espanol de Medula O, German High-Grade Lymphoma Study G, German Hodgkin\u2019s Study G, Japanese Lymphorra Study G, Lymphoma Study A, Group NCT, Nordic Lymphoma Study G, Southwest Oncology G, United Kingdom National Cancer Research I","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance AL, Lymphoma G, Eastern Cooperative Oncology G, European Mantle Cell Lymphoma C, Italian Lymphoma F, European Organisation for R, Treatment of Cancer\/Dutch Hemato-Oncology G, Grupo Espanol de Medula O, German High-Grade Lymphoma Study G, German Hodgkin\u2019s Study G, Japanese Lymphorra Study G, Lymphoma Study A, Group NCT, Nordic Lymphoma Study G, Southwest Oncology G, United Kingdom National Cancer Research I (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"3301_CR6","first-page":"1389","volume":"98","author":"Chinese Anti-Cancer Association Lymphoma Branch","year":"2018","unstructured":"Chinese Anti-Cancer Association Lymphoma Branch (2018) Chinese expert consensus on the diagnosis and treatment of LAHS. Zhong Hua Yi Xue Za Zhi 98:1389\u20131393","journal-title":"Zhong Hua Yi Xue Za Zhi"},{"issue":"13","key":"3301_CR7","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","volume":"127","author":"R Das","year":"2016","unstructured":"Das R, Guan P, Sprague L, Verbist K, Tedrick P, An QA, Cheng C, Kurachi M, Levine R, Wherry EJ, Canna SW, Behrens EM, Nichols KE (2016) Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood 127(13):1666\u20131675. https:\/\/doi.org\/10.1182\/blood-2015-12-684399","journal-title":"Blood"},{"issue":"22","key":"3301_CR8","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM, Histiocyte S (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672\u20132681. https:\/\/doi.org\/10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"issue":"6","key":"3301_CR9","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.clml.2014.06.025","volume":"14","author":"A Ghose","year":"2014","unstructured":"Ghose A, Yellu M, Wise-Draper T, Sharma D, Qualtieri J, Latif T, Medlin S (2014) Lymphoma presenting as secondary HLH: a review with a tale of two cases. Clin Lymphoma Myeloma & Leukemia 14(6):e187\u2013e193. https:\/\/doi.org\/10.1016\/j.clml.2014.06.025","journal-title":"Clin Lymphoma Myeloma & Leukemia"},{"issue":"5","key":"3301_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(sici)1096-911x(199705)28:5<342::aid-mpo3>3.0.co;2-h","volume":"28","author":"JI Henter","year":"1997","unstructured":"Henter JI, Arico M, Egeler RM, Elinder G, Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S, Webb D (1997) HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 28(5):342\u2013347. https:\/\/doi.org\/10.1002\/(sici)1096-911x(199705)28:5%3c342:aid-mpo3%3e3.0.co;2-h","journal-title":"Med Pediatr Oncol"},{"issue":"7","key":"3301_CR11","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G, Histocyte S (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100(7):2367\u20132373. https:\/\/doi.org\/10.1182\/blood-2002-01-0172","journal-title":"Blood"},{"issue":"2","key":"3301_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"3301_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K, Kawa K (2007) Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86(1):58\u201365. https:\/\/doi.org\/10.1532\/IJH97.07012","journal-title":"Int J Hematol"},{"issue":"4","key":"3301_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","volume":"28","author":"GE Janka","year":"2014","unstructured":"Janka GE, Lehmberg K (2014) Hemophagocytic syndromes\u2013an update. Blood Rev 28(4):135\u2013142. https:\/\/doi.org\/10.1016\/j.blre.2014.03.002","journal-title":"Blood Rev"},{"issue":"1","key":"3301_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1365-2141.2003.04726.x","volume":"124","author":"GE Janka","year":"2004","unstructured":"Janka GE, Schneider EM (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 124(1):4\u201314. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04726.x","journal-title":"Br J Haematol"},{"issue":"4","key":"3301_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/10245332.2017.1385191","volume":"23","author":"Z Jin","year":"2018","unstructured":"Jin Z, Wang Y, Wang J, Wu L, Pei R, Lai W, Wang Z (2018) Multivariate analysis of prognosis for patients with natural killer\/T cell lymphoma-associated hemophagocytic lymphohistiocytosis. Hematology 23(4):228\u2013234. https:\/\/doi.org\/10.1080\/10245332.2017.1385191","journal-title":"Hematology"},{"issue":"23","key":"3301_CR17","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Rosee","year":"2019","unstructured":"La Rosee P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, Birndt S, Gil-Herrera J, Girschikofsky M, Jordan MB, Kumar A, van Laar JAM, Lachmann G, Nichols KE, Ramanan AV, Wang Y, Wang Z, Janka G, Henter JI (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133(23):2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"issue":"4","key":"3301_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.13462","volume":"170","author":"K Lehmberg","year":"2015","unstructured":"Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Muller I, Suttorp M, Bernig T, Beutel K, Bode SF, Kentouche K, Kolb R, Langler A, Minkov M, Schilling FH, Schmid I, Vieth S, Ehl S, Zur Stadt U, Janka GE (2015) Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol 170(4):539\u2013549. https:\/\/doi.org\/10.1111\/bjh.13462","journal-title":"Br J Haematol"},{"issue":"5","key":"3301_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00005-014-0274-1","volume":"62","author":"I Malinowska","year":"2014","unstructured":"Malinowska I, Machaczka M, Popko K, Siwicka A, Salamonowicz M, Nasilowska-Adamska B (2014) Hemophagocytic syndrome in children and adults. Arch Immunol Ther Exp 62(5):385\u2013394. https:\/\/doi.org\/10.1007\/s00005-014-0274-1","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"3301_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pbc.24188","volume":"60","author":"RA Marsh","year":"2013","unstructured":"Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB (2013) Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 60(1):101\u2013109. https:\/\/doi.org\/10.1002\/pbc.24188","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"3301_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","volume":"128","author":"S Maschalidi","year":"2016","unstructured":"Maschalidi S, Sepulveda FE, Garrigue A, Fischer A, de Saint Basile G (2016) Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Blood 128(1):60\u201371. https:\/\/doi.org\/10.1182\/blood-2016-02-700013","journal-title":"Blood"},{"key":"3301_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/asheducation-2015.1.183","volume":"2015","author":"S Nikiforow","year":"2015","unstructured":"Nikiforow S, Berliner N (2015) The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults. Hematol Am Soc Hematol Educ Progr 2015:183\u2013189. https:\/\/doi.org\/10.1182\/asheducation-2015.1.183","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"issue":"9","key":"3301_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ajh.21236","volume":"83","author":"RL Olin","year":"2008","unstructured":"Olin RL, Nichols KE, Naghashpour M, Wasik M, Shelly B, Stadtmauer EA, Vogl DT (2008) Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol 83(9):747\u2013749. https:\/\/doi.org\/10.1002\/ajh.21236","journal-title":"Am J Hematol"},{"issue":"4","key":"3301_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","volume":"36","author":"JJ O\u2019Shea","year":"2012","unstructured":"O\u2019Shea JJ, Plenge R (2012) JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36(4):542\u2013550. https:\/\/doi.org\/10.1016\/j.immuni.2012.03.014","journal-title":"Immunity"},{"issue":"5","key":"3301_CR25","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1097\/MJT.0000000000000035","volume":"23","author":"R Rios-Fernandez","year":"2016","unstructured":"Rios-Fernandez R, Callejas-Rubio JL, Garcia-Rodriguez S, Sancho J, Zubiaur M, Ortego-Centeno N (2016) Tocilizumab as an adjuvant therapy for hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. Am J Ther 23(5):e1193\u2013e1196. https:\/\/doi.org\/10.1097\/MJT.0000000000000035","journal-title":"Am J Ther"},{"issue":"2","key":"3301_CR26","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1002\/ajh.24971","volume":"93","author":"J Slostad","year":"2018","unstructured":"Slostad J, Hoversten P, Haddox CL, Cisak K, Paludo J, Tefferi A (2018) Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: a single patient experience. Am J Hematol 93(2):E47\u2013E49. https:\/\/doi.org\/10.1002\/ajh.24971","journal-title":"Am J Hematol"},{"issue":"1","key":"3301_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1182\/blood-2018-05-845818","volume":"132","author":"B Tesi","year":"2018","unstructured":"Tesi B, Bryceson YT (2018) HLH: genomics illuminates pathophysiological diversity. Blood 132(1):5\u20137. https:\/\/doi.org\/10.1182\/blood-2018-05-845818","journal-title":"Blood"},{"key":"3301_CR28","doi-asserted-by":"publisher","first-page":"155219878774","DOI":"10.1177\/1078155219878774","volume":"1078","author":"T Trantham","year":"2019","unstructured":"Trantham T, Auten J, Muluneh B, Van Deventer H (2019) Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: a cautionary tale. J Oncol Pharm Pract 1078:155219878774. https:\/\/doi.org\/10.1177\/1078155219878774","journal-title":"J Oncol Pharm Pract"},{"issue":"17","key":"3301_CR29","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","volume":"118","author":"H Trottestam","year":"2011","unstructured":"Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Ladisch S, Webb D, Janka G, Henter JI, Histiocyte S (2011) Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118(17):4577\u20134584. https:\/\/doi.org\/10.1182\/blood-2011-06-356261","journal-title":"Blood"},{"issue":"1","key":"3301_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/07853890500465189","volume":"38","author":"JW Verbsky","year":"2006","unstructured":"Verbsky JW, Grossman WJ (2006) Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 38(1):20\u201331. https:\/\/doi.org\/10.1080\/07853890500465189","journal-title":"Ann Med"},{"issue":"1","key":"3301_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3760\/cma.j.issn.0253-2727.2019.01.014","volume":"40","author":"JS Wang","year":"2019","unstructured":"Wang JS, Wang YN, Wu L, Lai WY, Wang Z (2019) Refractory\/relapsed hemophagocytic lymphohistiocytosis treated with ruxolitinib: three cases report and literatures review. Zhonghua xue ye xue za zhi\u2009=\u2009Zhonghua xueyexue zazhi 40(1):73\u201375. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2019.01.014","journal-title":"Zhonghua xue ye xue za zhi\u2009=\u2009Zhonghua xueyexue zazhi"},{"issue":"4","key":"3301_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/107327481402100406","volume":"21","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zhou J, Sokol L (2014) Hereditary and acquired hemophagocytic lymphohistiocytosis. Cancer Control 21(4):301\u2013312. https:\/\/doi.org\/10.1177\/107327481402100406","journal-title":"Cancer Control"},{"issue":"6","key":"3301_CR33","first-page":"769","volume":"38","author":"WB Zhuo","year":"2018","unstructured":"Zhuo WB, Gao Y, Yang CY, Xu Y, Zhang YT, Zhu DM, Ping BH (2018) Clinical characteristics of hemophagocytic syndrome: analysis of 46 cases. J South Med Univ 38(6):769","journal-title":"J South Med Univ"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03301-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03301-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:03:59Z","timestamp":1625184239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03301-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["3301"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03301-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangdong Pharmaceutical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The need for informed consent was waived by the committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}